11/17/2026 | Press release | Distributed by Public on 11/17/2026 16:12
Filed pursuant to Rule 424(b)(5)
Registration No. 333-290712
PROSPECTUS SUPPLEMENT
(To prospectus dated November 26, 2025 and
prospectus supplement dated January 20, 2026)
$100,000,000
STABLECOIN DEVELOPMENT CORPORATION
Common Stock
This prospectus supplement (this "Prospectus Supplement") amends and supplements the prospectus supplement dated January 20, 2026 (the "ATM Prospectus"). This Prospectus Supplement should be read in conjunction with the ATM Prospectus and the accompanying base prospectus included in the Registration Statement on Form S-3 (File No. 333-290712) filed with the Securities and Exchange Commission (the "Commission") under the Securities Act of 1933, as amended (the "Securities Act"), on October 3, 2025, as amended on November 25, 2025, and declared effective by the Commission on November 26, 2025 (the "Registration Statement"), relating to the offer and sale of shares of our common stock, par value $0.01 per share ("Common Stock"), from time to time pursuant to the terms of the ATM Sales Agreement dated January 20, 2026 (the "Sales Agreement") with Virtu Americas LLC ("Virtu"), acting as sales agent or principal. This Prospectus Supplement is qualified by reference to the ATM Prospectus, except to the extent that the information herein amends or supersedes the information contained in the ATM Prospectus. This Prospectus Supplement is not complete without and may only be delivered or utilized in connection with the ATM Prospectus, and any future amendments or supplements thereto.
We previously filed the ATM Prospectus for the offer and sale of up to $100.0 million of shares of our Common Stock pursuant to the Sales Agreement under the Registration Statement. As of November 16, 2026, we have offered and sold shares of our Common Stock having an aggregate offering price of approximately $64.3 million pursuant to the Sales Agreement and the ATM Prospectus.
We are filing this Prospectus Supplement to supplement the ATM Prospectus to increase the aggregate amount we intend to sell pursuant to the Sales Agreement. As of the date of this Prospectus Supplement, we are offering up to an additional aggregate of $100.0 million of shares of our Common Stock for sale under the Sales Agreement, not including the shares of Common Stock previously sold pursuant to the Sales Agreement. Accordingly, based on sales through November 16, 2026, we may offer and sell up to approximately $135.7 million of shares of our Common Stock under the Sales Agreement, consisting of $35.7 million remaining under the ATM Prospectus and $100.0 million offered by this Prospectus Supplement.
Our Common Stock is listed on the NYSE American, LLC (the "NYSE American") under the symbol "SDEV". On November 16, 2026, the last reported sale price of our Common Stock on the NYSE American was $0.71 per share.
Sales of our Common Stock, if any, under this Prospectus Supplement may be made by any method deemed to be an "at the market offering" as defined in Rule 415(a)(4) under the Securities Act. Virtu is not required to sell any specific amount of securities, but will act as our sales agent using commercially reasonable efforts consistent with its normal trading and sales practices, on mutually agreed terms between Virtu and us. There is no arrangement for funds to be received in any escrow, trust or similar arrangement.
Investing in our Common Stock involves a high degree of risk. Before making an investment decision, please read the information under the heading "Risk Factors" beginning on page S-6 of the ATM Prospectus, as well as the risks set forth in our most recent Annual Report on Form 10-K, as amended, and the other reports we file with the Commission pursuant to the Securities Exchange Act of 1934, as amended, including our Quarterly Reports on Form 10-Q and our Current Report on Form 8-K filed on October 5, 2026, which are incorporated by reference into this Prospectus Supplement and the ATM Prospectus, for a discussion of certain risks that should be considered in connection with an investment in our Common Stock.
Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or passed upon the adequacy or accuracy of this prospectus supplement. Any representation to the contrary is a criminal offense.
Virtu
The date of this prospectus supplement is November 17, 2026.